IRIS
FALCIANI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.768
EU - Europa 8.088
AS - Asia 3.822
SA - Sud America 641
Continente sconosciuto - Info sul continente non disponibili 264
AF - Africa 189
OC - Oceania 17
Totale 21.789
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.615
IT - Italia 1.733
GB - Regno Unito 1.641
RU - Federazione Russa 1.473
CN - Cina 1.365
SG - Singapore 1.073
IE - Irlanda 875
SE - Svezia 557
BR - Brasile 507
UA - Ucraina 449
DE - Germania 436
VN - Vietnam 391
FR - Francia 348
HK - Hong Kong 291
KR - Corea 213
FI - Finlandia 203
IN - India 126
ZA - Sudafrica 107
ES - Italia 90
BD - Bangladesh 86
CA - Canada 78
PL - Polonia 60
BE - Belgio 54
AR - Argentina 46
NL - Olanda 45
PK - Pakistan 36
MX - Messico 35
JP - Giappone 33
TR - Turchia 33
IR - Iran 25
AT - Austria 22
CZ - Repubblica Ceca 21
VE - Venezuela 18
CL - Cile 17
EC - Ecuador 17
NG - Nigeria 17
IQ - Iraq 16
CH - Svizzera 15
KE - Kenya 15
AU - Australia 14
ID - Indonesia 13
AZ - Azerbaigian 12
PH - Filippine 12
UZ - Uzbekistan 12
CO - Colombia 11
LT - Lituania 11
IL - Israele 10
KZ - Kazakistan 10
PE - Perù 10
RO - Romania 10
TN - Tunisia 10
DZ - Algeria 9
JO - Giordania 9
MA - Marocco 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
SA - Arabia Saudita 8
PY - Paraguay 7
CI - Costa d'Avorio 6
CR - Costa Rica 6
DK - Danimarca 6
EU - Europa 6
BY - Bielorussia 5
DO - Repubblica Dominicana 5
EE - Estonia 5
NP - Nepal 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
BO - Bolivia 4
ET - Etiopia 4
JM - Giamaica 4
LA - Repubblica Popolare Democratica del Laos 4
MY - Malesia 4
OM - Oman 4
RS - Serbia 4
TH - Thailandia 4
AL - Albania 3
AM - Armenia 3
BB - Barbados 3
GD - Grenada 3
GY - Guiana 3
HN - Honduras 3
KG - Kirghizistan 3
LB - Libano 3
LV - Lettonia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PA - Panama 3
SI - Slovenia 3
BA - Bosnia-Erzegovina 2
GR - Grecia 2
GT - Guatemala 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TW - Taiwan 2
AO - Angola 1
BS - Bahamas 1
CY - Cipro 1
GE - Georgia 1
Totale 21.517
Salva come PNG Salva come JPEG
Città #
Southend 1.445
Dallas 986
Dublin 866
Ashburn 669
Fairfield 662
Singapore 590
Chandler 481
Moscow 421
Siena 419
San Jose 391
Santa Clara 389
Jacksonville 365
Milan 350
Beijing 347
Woodbridge 341
Ann Arbor 297
Houston 279
Seattle 271
Hong Kong 270
Wilmington 270
Hefei 263
Council Bluffs 243
Menlo Park 234
Cambridge 213
Seoul 209
Los Angeles 157
New York 149
Princeton 144
Rome 144
The Dalles 123
Nanjing 112
Florence 110
Johannesburg 100
Ho Chi Minh City 98
Helsinki 87
Munich 86
Lauterbourg 82
Dong Ket 81
Boardman 76
Hanoi 70
Málaga 60
Shanghai 59
Columbus 54
San Mateo 54
Buffalo 52
Nanchang 49
São Paulo 47
San Diego 46
Fremont 40
London 39
Brussels 38
Orem 38
Bengaluru 36
Dearborn 34
Turku 32
Warsaw 32
Brooklyn 30
Chicago 30
Hebei 30
Shenyang 30
Redwood City 28
Phoenix 27
Montreal 26
Tianjin 26
Düsseldorf 24
Kunming 24
Toronto 24
Tokyo 23
Washington 23
Da Nang 22
Frankfurt am Main 22
Redondo Beach 22
Bagno a Ripoli 21
Stockholm 20
Lappeenranta 19
Chennai 18
Porto Alegre 18
Abuja 17
Atlanta 17
Brno 17
Dhaka 17
Figino 17
Turin 17
Belo Horizonte 16
Denver 16
Jiaxing 16
Paris 16
Amsterdam 15
Changsha 15
Manchester 15
Mexico City 15
Nuremberg 15
Poplar 15
Rio de Janeiro 15
San Francisco 15
Gdansk 14
Naples 14
Vienna 14
Boston 13
Brasília 13
Totale 14.461
Salva come PNG Salva come JPEG
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 388
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 379
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 373
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 372
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 348
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 337
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 333
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 319
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 318
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 317
A new NT4 peptide-based drug delivery system for cancer treatment 314
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 312
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 311
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 307
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 305
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 302
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 298
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 295
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 288
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 284
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 283
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 282
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 281
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 277
Tumor imaging with tetrabranched neurotensin 273
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 273
Branched peptides as bioactive molecules for drug design 273
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 267
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 262
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 260
Branched Neurotensin For Tumor Targeting 259
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 257
Exploration of novel thiobarbituric acid- rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors 256
Bioactive peptides from libraries 255
Branched peptides for tumor diagnosis and therapy 251
Nanoparticles exposing neurotensin tumor-specific drivers 250
Branched peptides as targeting agents for tumor imaging and therapy 245
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 243
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 242
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 239
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 238
A Multidisciplinary Approach for the Identification ofNovel HIV-1 Non-Nucleoside Reverse TranscriptaseInhibitors: S-DABOCs and DAVPs 235
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 233
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate 232
Branched Neurotensin peptides for tumor personalized therapy 231
Branched peptides as therapeutics 230
Branched multimeric peptides for tumor diagnosis and therapy 228
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 227
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 226
Synthetic peptides in the form of dendrimers become resistant to protease activity 224
Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles 223
The development of antimicrobial peptides as new antibacterial drugs 221
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 217
The antimicrobial peptide M33. An example of drug development 217
Branched neurotensin for tumor targeting 216
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 215
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 215
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 212
Tumor selective targeting by branched peptides 210
Are periodontitis and psoriasis associated? A pre-clinical murine model 209
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 209
Molecular basis of branched peptides resistance to enzyme proteolysis 207
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 202
Neurotensin-derived branched peptides and uses thereof 196
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity. 189
Synthetic antidotes against snake neurotoxins 185
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 184
Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin 180
NMR and MD studies on the interaction between ligand peptides and alpha-bungarotoxin 177
In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection 176
The antimicrobial peptide M33. An example of drug development 171
Tumor imaging with tetrabranched neurotensin 171
Branched neurotensin peptides for tumor targeting 168
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 167
Branched peptides as novel tumor-targeting agents for bladder cancer 166
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 165
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 164
Dendrimeric peptides for tumor targeting 161
Oligo-branched peptides for tumor targeting: From magic bullets to magic forks 159
The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide 154
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo 151
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 147
Synthetic inhibitors of anthrax lethal toxin 146
Synthetic peptides in the form of dendrimers can become resistant to protease activity 143
Extracellular Vesicles of Pseudomonas: Friends and Foes 142
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 141
Structurally driven selection of human hepatitis C virus mimotopes. 136
Strong synthetic inhibitors of anthrax lethal toxin 128
Rationally designed affinity maturation of a synthetic antidote against alpha-bungarotoxin 118
Peptide Drugs 117
null 105
Models of in-vivo Bacterial Infections for the Development of Antimicrobial Peptide-Based Drugs 100
Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer 99
A peptide-based medical device for the selective removal of inflammatory factors from the blood of people with sepsis 88
Establishment and application of a vesicle extraction method for clinical strains of Pseudomonas aeruginosa 83
null 78
Establishment and application of a vesicle extraction method for clinical strains of Pseudomonas aeruginosa 29
The Synergetic Effect of Periodontal Therapy and TNF-α Inhibitor for the Treatment of Comorbid Periodontitis and Psoriasis 23
Ex-vivo evaluation of intratubular antibacterial activity and biocompatibility of two hydraulic calcium silicate-based endodontic sealers 20
SET-M33 peptide as a selective in vitro antimicrobial agent against the porcine respiratory pathogen Glaesserella parasuis 19
Totale 21.751
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.954
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.954
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.169 0 122 79 132 85 51 51 77 48 151 127 246
2022/20231.766 94 186 217 226 188 337 41 145 142 82 79 29
2023/20241.406 45 41 125 81 61 392 489 29 7 27 18 91
2024/20252.895 56 130 330 173 351 157 119 188 221 118 297 755
2025/20267.293 530 936 819 880 1.370 258 741 227 312 440 245 535
2026/2027491 314 177 0 0 0 0 0 0 0 0 0 0
Totale 21.789